Navigation Links
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
Date:5/18/2008

achieve any particular levels of revenue in the future. In particular, management's expectations regarding RAD001 could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated, or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events, or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides healthcare solutions that address the evolving need
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
2. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
3. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
4. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
5. Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
7. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
8. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
9. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
10. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
11. Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  Hologic, Inc. (NASDAQ: ... of the 2.00% Convertible Exchange Senior Notes due 2037 ... Wilmington Trust Company, the trustee, paying agent and conversion ... convert the notes.  This conversion right is subject to ... dated as of December 10, 2007, as supplemented by ...
(Date:4/1/2015)... and ASPEN, Colo. , ... partnership with the Chris Klug Foundation (CKF), is pleased to ... now being accepted for the award, which will recognize ... of life, whether it is a career accomplishment, participation ... fulfilling life with family and loved ones. ...
(Date:4/1/2015)... , Mar. 31, 2015 Research and Markets ... addition of the "Metabolic Testing Market by ... by Application (Critical Care, Lifestyle Diseases), by Technology ... Sports, Hospital) - Global Forecast to 2019 " ... global metabolic testing market is expected to reach ...
Breaking Medicine Technology:Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3Global Metabolic Testing (CPET, Body Composition Analysis, ECG, Portable System) Market 2015-2019 - REE, Body Composition Analysis for Gyms, Sports & Hospital 2
(Date:4/1/2015)... (PRWEB) April 01, 2015 Baby Bellies ... providing the latest information on the top products and ... set the Guinness World Records title for "Mommy Moments” ... of the 1st annual Baby Bellies & Beyond Expo ... and the Guinness World Record will commence at 11:00am ...
(Date:4/1/2015)... New York, New York (PRWEB) April 01, 2015 ... litigation housing hundreds of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ... According to the calendar for the Philadelphia Court of ... in Court Room 206, City Hall. Court records indicate ... liability claims filed on behalf of Risperdal users who ...
(Date:4/1/2015)... April 01, 2015 BioPlus Specialty ... specialty pharmacies, has released a new app to keep ... for treating chronic hepatitis C virus (HCV) infection. This ... on information from the American Association for the Study ... , Numerous new direct-acting oral medications to treat HCV ...
(Date:4/1/2015)... EAGAN, Minn. (April 1, 2015) —Blue Cross and ... (Blue Cross) today announced audited financial results for 2014. ... of $61.5 million, reflecting positive investment portfolio performance that ... operating loss of $8.2 million on full-year revenues of ... of one percent (0.1%). , Blue Cross reported ...
(Date:4/1/2015)... 2015 Dr. Daniel C. Stewart ... April to discuss the benefits of the LANAP® treatment ... from periodontal disease. People who live in Howard County, ... disease can now visit Dr. Stewart, a Maryland dentist, ... With the LANAP® protocol, which is a laser gum ...
Breaking Medicine News(10 mins):Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3
... researchers may have found a clue to the blues ... be triggered by the same mechanisms that enable the ... in the December issue of Neuropsychopharmacology, Chong-Bin ... Ph.D., and colleagues activated the immune system in mice ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... facilities in the state of Illinois don,t make it to ... state. But the most severely injured patients did ... are appropriately triaging patients, according to a study in the ...
... MONDAY, Dec. 20 (HealthDay News) -- Continuing a 12-year climb, ... almost one-third of the births in the United States, ... up since 1996 across the board for all age groups ... study and an analyst with the National Center for Health ...
... HealthDay Reporter , MONDAY, Dec. 20 (HealthDay News) ... receptor antagonists, may raise the risk of pneumonia, new research ... studies on heartburn drugs published between 1985 and 2009. ... drugs is associated with an increased risk of pneumonia," said ...
... prone to develop genital cancer, especially as they grow older. ... both sexes suffer from the condition, which is extremely difficult ... Because of the similarity of the disease to human genital ... responsible. Several human genital cancers, including cervical tumours, are ...
... are more effective than anti-inflammatory drugs and cortisone injections ... This is the conclusion of a thesis presented at ... among other topics, the selection of treatment by healthcare ... and the results from a training programme for tennis ...
Cached Medicine News:Health News:Link between depression and inflammatory response found in mice 2Health News:Most Trauma Patients Not Transferred Within Mandated Time Frame in Illinois 2Health News:Most Trauma Patients Not Transferred Within Mandated Time Frame in Illinois 3Health News:C-Sections Continue 12-Year Climb: U.S. Report 2Health News:C-Sections Continue 12-Year Climb: U.S. Report 3Health News:Heartburn Drugs May Raise Pneumonia Risk 2Health News:Heartburn Drugs May Raise Pneumonia Risk 3Health News:A possible cause -- and cure -- for genital cancer in horses? 2Health News:Training the best treatment for tennis elbow 2
... The Luna is based on a ... At ovulation, a woman's most fertile time, ... egg to be released. At the same ... salt in your saliva. It is these ...
... The FSH Menopause Predictor Test is ... the detection of Follicle Stimulating Hormone ... of body hormone changes related to ... of menopause. The FHS Menopause ...
Inquire...
Pronto Dry is intended for use for the detection of urease enzyme in gastric mucosal biopsy specimens....
Medicine Products: